Indrani Franchini is responsible for maintaining an enterprise-wide culture of ethics and compliance focused on managing key areas of risk to Alexion, while maintaining the policies of the company and interacting with external regulators. Her global team manages all compliance policies and processes, develops training in all key risk areas, oversees internal investigations and disciplinary actions, and works to enhance key auditing and monitoring within the company.
Priviously, Ms. Franchini served as Vice President, Chief Compliance Officer and Assistant Corporate Secretary of Hess Corporation, a global, integrated energy company based in New York City for five years. As their first Chief Compliance Officer, she built their global compliance program to address key risks in the energy industry. She managed a global team and worked regularly with senior management on all aspects of compliance and governance.
Prior to her role at Hess, Ms. Franchini was with Pfizer Inc. for nearly nine years, where she was Chief Compliance Counsel, Vice President, and Assistant General Counsel for the company’s Global Pharmaceutical Business. In this role, she oversaw compliance for the development, marketing, and promotion of Pfizer’s pharmaceutical assets, including managing, coordinating, and overseeing compliance leads in five business units across five global regions.
Prior to that, Ms. Franchini spent five years with the law firm Milbank, Tweed, Hadley & McCloy LLP, as an Associate in both the New York and Tokyo offices.
Ms. Franchini graduated cum laude with a bachelor’s degree in Politics from Princeton University and a J.D. from the University of Michigan Law School, where she was Editor in Chief of the International Journal of Law. She is currently a board member of LatinoJustice PRLDEF, Hispanic Federation, and the Association of Latino Alumni of Princeton, and is fluent in English, Spanish, and Japanese.
What is Indrani Lall Franchini's net worth?
The estimated net worth of Indrani Lall Franchini is at least $638,750.00 as of February 2nd, 2023. Ms. Franchini owns 3,500 shares of Alexion Pharmaceuticals stock worth more than $638,750 as of April 28th. This net worth estimate does not reflect any other investments that Ms. Franchini may own. Learn More about Indrani Lall Franchini's net worth.
How old is Indrani Lall Franchini?
Ms. Franchini is currently 49 years old. There are 5 older executives and no younger executives at Alexion Pharmaceuticals. The oldest executive at Alexion Pharmaceuticals is Dr. John J. Orloff, Exec. VP and Head of R&D, who is 64 years old. Learn More on Indrani Lall Franchini's age.
How do I contact Indrani Lall Franchini?
Has Indrani Lall Franchini been buying or selling shares of Alexion Pharmaceuticals?
Indrani Lall Franchini has not been actively trading shares of Alexion Pharmaceuticals during the last ninety days. Most recently, Indrani Lall Franchini sold 4,500 shares of the business's stock in a transaction on Monday, July 1st. The shares were sold at an average price of $132.78, for a transaction totalling $597,510.00. Following the completion of the sale, the executive vice president now directly owns 29,627 shares of the company's stock, valued at $3,933,873.06. Learn More on Indrani Lall Franchini's trading history.
Who are Alexion Pharmaceuticals' active insiders?
